30 years in postmarketing surveillance. A personal perspective

This publication has 11 references indexed in Scilit:

• Prescriber profile and post-marketing surveillance
  The Lancet, 1993
• Review of company postmarketing surveillance studies.
  BMJ, 1992
• Jaundice after repeated exposure to halothane: a further analysis of reports to the Committee on Safety of Medicines.
  BMJ, 1978
• Untoward effects associated with practolol administration: oculomucocutaneous syndrome.
  BMJ, 1975
• Jaundice after Repeated Exposure to Halothane: An Analysis of Reports to the Committee on Safety of Medicines
  BMJ, 1974
• ROLE OF DRUG-REACTION MONITORING IN THE INVESTIGATION OF THROMBOSIS AND “THE PILL”
  British Medical Bulletin, 1970
• Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs
  BMJ, 1970
• Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age.
  BMJ, 1968
• Risk of thromboembolic disease in women taking oral contraceptives. A preliminary communication to the Medical Research Council by a Subcommittee.
  BMJ, 1967
• The design and logic of a monitor of drug use
  Journal of Chronic Diseases, 1965